other material
confidence high
sentiment neutral
materiality 0.10
C4 Therapeutics board adopts annual advisory vote on exec compensation after stockholder recommendation
C4 Therapeutics, Inc.
- Stockholders voted in favor of a 1-year frequency for advisory votes on named executive officer compensation.
- Board determined to hold annual non-binding advisory votes until the next required frequency proposal.
- Amendment filed solely to disclose this frequency decision; original 8-K reported June 22, 2022 annual meeting results.